IMMUTIN®
Product characteristics
Active substance: Imatinib
Therapeutic group: Antineoplastic and immunomodulatory drugs. Antineoplastic drugs. Other antineoplastic drugs. Protein kinase inhibitors. Tyrosine kinase BCR-ABL inhibitors. Imatinib. ATC code L01ЕА01
Form: 5 tablets in a blister pack. 6 blister packs in a cardboard box with a hologram of the manufacturer.
Package Type: Film-coated tablets, 200 mg
Download instruction